|1|Protective effect of Co-enzyme Q10 On doxorubicin-induced cardiomyopathy of rat hearts. (27087047)
Chen P.Y.... Huang C.Y.
|2|Matricellular protein CCN1 mediates doxorubicin-induced cardiomyopathy in mice. (27167338)
Hsu P.L.... Mo F.E.
|3|Protective effects of endothelin receptor A and B inhibitors against doxorubicin-induced cardiomyopathy. (25660617)
Schwebe M.... Bien-MAPller S.
|4|A metabolomic study of rats with doxorubicin-induced cardiomyopathy and Shengmai injection treatment. (25938766)
Chen Y.... Xiang Y.
|5|Potent Paracrine Effects of human induced Pluripotent Stem Cell-derived Mesenchymal Stem Cells Attenuate Doxorubicin-induced Cardiomyopathy. (26057572)
Zhang Y.... Lian Q.
|6|Protective effect of cilostazol against doxorubicin-induced cardiomyopathy in mice. (26191652)
Koh J.S.... Roh G.S.
|7|Early Administration of Carvedilol Protected against Doxorubicin-Induced Cardiomyopathy. (26511374)
Chen Y.L.... Yip H.K.
|8|Oleuropein prevents doxorubicin-induced cardiomyopathy interfering with signaling molecules and cardiomyocyte metabolism. (24486195)
Andreadou I.... Iliodromitis E.K.
|9|Embryonic Stem Cells and Released Factors Stimulate c-kit (+ve) /FLK-1(+ve) Progenitor Cells and Promote Neovascularization in Doxorubicin-induced Cardiomyopathy. (24593859)
Singla D.K.... Abdelli L.S.
|10|Interrelation between Expression of ADAM 10 and MMP 9 and Synthesis of Peroxynitrite in Doxorubicin Induced Cardiomyopathy. (24244825)
|11|Manipulation of Cardiac PI3K/Akt Signaling by Apoptosis regulator through modulating IAP expression (ARIA) Regulates Cardiomyocyte Death during the Doxorubicin-induced Cardiomyopathy. (24338479)
Kitamura Y.... Ikeda K.
|12|Antioxidant, lipid lowering, and membrane stabilization effect of sesamol against doxorubicin-induced cardiomyopathy in experimental rats. (24228260)
Chennuru A.... Saleem M.T.
|13|Increased beta2-adrenoceptors in doxorubicin-induced cardiomyopathy in rat. (23741376)
Merlet N.... Gauthier C.
|14|Doxorubicin-induced cardiomyopathy: from molecular mechanisms to therapeutic strategies. (22465037)
Octavia Y.... Moens A.L.
|15|Effects of the antioxidant agent tempol on periapical lesions in rats with doxorubicin-induced cardiomyopathy. (22244634)
Brilhante Wolle C.F.... Campos M.M.
|16|Fosinopril attenuates the doxorubicin-induced cardiomyopathy by restoring the function of sarcoplasmic reticulum. (22729889)
Zhang Y.C.... Xu W.P.
|17|Inorganic nitrate therapy improves Doxorubicin-induced cardiomyopathy a new window for an affordable cardiovascular therapy for everyone? (21596235)
Daiber A.... MA1nzel T.
|18|Pretreatment with angiotensin-converting enzyme inhibitor improves doxorubicin-induced cardiomyopathy via preservation ofA mitochondrial function. (21094500)
Hiona A.... Wu J.C.
|19|Thrombopoietin protects against doxorubicin-induced cardiomyopathy, improves cardiac function, and reversely alters specific signalling networks. (21330293)
Chan K.Y.... Sung R.Y.
|20|Calpain-mediated dystrophin disruption may be a potential structural culprit behind chronic doxorubicin-induced cardiomyopathy. (21946105)
Campos E.C.... Rossi M.A.
|21|Adiponectin protects against doxorubicin-induced cardiomyopathy by anti-apoptotic effects through AMPK up-regulation. (20978005)
Konishi M.... Isobe M.
|22|Involvement of advanced glycation end-products, pentosidine and N(epsilon)-(carboxymethyl)lysine, in doxorubicin-induced cardiomyopathy in rats. (20004697)
Moriyama T.... Horie T.
|23|Long-acting phosphodiesterase-5 inhibitor tadalafil attenuates doxorubicin-induced cardiomyopathy without interfering with chemotherapeutic effect. (20543097)
Koka S.... Kukreja R.C.
|24|CB1 cannabinoid receptors promote oxidative stress and cell death in murine models of doxorubicin-induced cardiomyopathy and in human cardiomyocytes. (19942623)
Mukhopadhyay P.... Pacher P.
|25|Cardioprotective effect of endogenous pituitary adenylate cyclase-activating polypeptide on Doxorubicin-induced cardiomyopathy in mice. (20378996)
Mori H.... Shioda S.
|26|Dexrazoxane protects against doxorubicin-induced cardiomyopathy: upregulation of Akt and Erk phosphorylation in a rat model. (18379782)
Xiang P.... Sung R.Y.
|27|Erythropoietin protects against doxorubicin-induced cardiomyopathy via a phosphatidylinositol 3-kinase-dependent pathway. (17928571)
Kim K.H.... Backx P.H.
|28|Granulocyte colony-stimulating factor improves left ventricular function of doxorubicin-induced cardiomyopathy. (17334414)
Li L.... Fujiwara H.
|29|Preventive cardioprotection of erythropoietin against doxorubicin-induced cardiomyopathy. (17924179)
Chen X.... Xu J.
|30|Overexpression of Nd1, a novel Kelch family protein, in the heart of transgenic mice protects against doxorubicin-induced cardiomyopathy. (16952015)
Matsudo Y.... Hatano M.
|31|Plasma concentrations of NT-pro-BNP and cardiac troponin-I in relation to doxorubicin-induced cardiomyopathy and cardiac function in childhood malignancy. (16127512)
Soker M.... Kervancioglu M.
|32|Concurrent therapies that protect against doxorubicin-induced cardiomyopathy. (15515283)
Simpson C.... Courville K.A.
|33|Protective effects of erdosteine against doxorubicin-induced cardiomyopathy in rats. (12518339)
FadillioA9lu E.... Kuku I.
|34|Molecular biology of doxorubicin-induced cardiomyopathy. (19644577)
Umlauf J.... HorkA1 M.
|35|Angiotensin II type 1a receptor mediates doxorubicin-induced cardiomyopathy. (12358147)
Toko H.... Komuro I.
|36|Increased plasma endothelin-1 and cardiac nitric oxide during doxorubicin-induced cardiomyopathy. (11589785)
Sayed-Ahmed M.M.... Osman A.M.
|37|Doxorubicin-induced cardiomyopathy. (10910374)
Otero F.J.... Sheahan R.G.
|38|Evaluation of cardiac adrenergic neuronal damage in rats with doxorubicin-induced cardiomyopathy using iodine-131 MIBG autoradiography and PGP 9.5 immunohistochemistry. (10901455)
Jeon T.J.... Cho S.H.
|39|Doxorubicin-induced cardiomyopathy. (10049085)
Lipshultz S.E.... Colan S.D.
|40|Doxorubicin-induced cardiomyopathy. (10049087)
|41|The role of iron in doxorubicin-induced cardiomyopathy. (9768818)
|42|Doxorubicin-induced cardiomyopathy treated with carvedilol. (9789703)
Fazio S.... SaccA L.
|43|Contractile failure in chronic doxorubicin-induced cardiomyopathy. (9344758)
Boucek R.J.... Olson R.D.
|44|Efficacy and safety of metoprolol in the treatment of doxorubicin-induced cardiomyopathy in pediatric patients. (7817916)
Shaddy R.E.... Renlund D.G.
|45|Improvement of doxorubicin induced cardiomyopathy in rats treated with insulin-like growth factor I. (8252601)
Ambler G.R.... Gluckman P.D.
|46|Etiology of sarcoplasmic reticulum calcium release channel lesions in doxorubicin-induced cardiomyopathy. (1314436)
Pessah I.N.... Giri S.N.
|47|Activity of receptors coupled to guanine nucleotide binding regulatory protein in doxorubicin induced cardiomyopathy. (1660348)
Fu L.X.... Hjalmarson A.
|48|Chronic doxorubicin induced cardiomyopathy in rabbits: mechanical, intracellular action potential, and beta adrenergic characteristics of the failing myocardium. (2170016)
Shenasa H.... Rouleau J.L.
|49|Heart transplantation in a child with doxorubicin-induced cardiomyopathy. (3054552)
Arico M.... Burgio G.R.
|50|The efficacy of N-acetylcysteine in preventing doxorubicin-induced cardiomyopathy in dogs. (6836323)
Unverferth D.V.... Hamlin R.L.